Inmune Bio Inc share price logo

Inmune Bio Inc Share Price

NASDAQ: INMB

Small Cap

$1.14

-0.06

(-5.42%)

as on

Inmune Bio Inc Stock Performance

as on March 28, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $1.13
    $1.20
    downward going graph

    0.88%

    Downside

    5.26%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $1.12
    $11.64
    downward going graph

    1.75%

    Downside

    921.05%

    Upside

    downward going graph

Inmune Bio Inc share price movements today

Previous Close
$1.20
Open
$1.20
Volume
654.0K
Day's Low - High
$1.13 - $1.20
52 Week Low - High
$1.12 - $11.64

Inmune Bio Inc Historical Returns

1 Month Return
-15.79 %
3 Month Return
-30 %
1 Year Return
-85.11 %
3 Year Return
-81.36 %
5 Year Return
0 %

Inmune Bio Inc Stock Fundamentals & Key Indicators

Check Inmune Bio Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$29.8M

EPS (TTM)

-1.61

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-3.59

Industry PE ratio

-4.068794117647059

PEG Ratio

0

EBITDA

-

Revenue (TTM)

50.0K

Profit Margin

0.00%

Return On Equity TTM

-155.77%

Inmune Bio Inc Stock Valuation

Track how Inmune Bio Inc P/E has moved over time to understand its valuation trends.

Inmune Bio Inc in the last 5 years

  • Overview

  • Trends

Lowest (-12.33x)

September 30, 2021

Industry (-4.07x)

March 30, 2026

Today (-3.59x)

March 30, 2026

Highest (-1.62x)

September 30, 2025

LowHigh

Today’s Price to Earnings Ratio: -3.59x

Inmune Bio Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Inmune Bio Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Inmune Bio Inc image
Inmune Bio Inc
BUY$29.8MNA-3.590.00%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$42.1B134.86%136.798.45%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$110.0B103.33%28.2532.94%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$32.5BNA115.055.37%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$78.0B56.74%17.7931.41%

Stock Returns calculator for Inmune Bio Inc Stock including INR - Dollar returns

The Inmune Bio Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Inmune Bio Inc investment value today

Current value as on today

₹16,786

Returns

-₹83,214

(-83.21%)

Returns from Inmune Bio Inc Stock

-₹84,840 (-84.84%)

Dollar Impact

₹1,627 (+1.63%)

Analyst Recommendation on Inmune Bio Inc Stock

Based on 9 analysts

BUY

88.89%

Buy

11.11%

Hold

0.00%

Sell

Based on 9 analysts, 88.89% of analysts recommend a 'BUY' rating for Inmune Bio Inc. Average target price of $7

Inmune Bio Inc Share Price Target

Get share price movements and forecasts by analysts on Inmune Bio Inc.

What analysts predicted

83.71%UPSIDE

Target Price

$7

Current Price

$1.14

Analyzed by

9 Analysts

Target

$7.00

Inmune Bio Inc target price $7, a slight upside of 83.71% compared to current price of $1.14. According to 9 analysts rating.

Inmune Bio Inc Stock’s Investor Sentiment and Interest

Search interest for Inmune Bio Inc Stock has increased by 39% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:39% versus previous 30 day period

Inmune Bio Inc Quarterly Profit & Loss

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Total Revenue
0
0
0
0
-
-
-
0
-
-
Gross Profit
0
0
0
0
-
-
-
0
-
0
Operating Income
-6
-8
-8
-11
-9
-12
-9
-9
-24
-7
EBITDA
-6
-8
-8
-11
-9
-12
-9
-9
-8
-6
Interest Expense
-
-
0
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
-6
-8
-8
-11
-9
-12
-9
-9
-24
-6
Income Tax Expense
-6
-8
14
-11
-9
-
-
-
-
-
Net Income
-6
-8
-8
-11
-9
-12
-9
-9
-24
-6
Net Profit Margin
-14132.61%
-19913.95%
-30028.57%
-78750.00%
0.00%
0.00%
0.00%
-19478.00%
0.00%
0.00%

Inmune Bio Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
-
-
-
-
77
0
0
0
0
0
Gross Profit
-
-
-
-
77
0
0
0
0
0
Operating Income
0
0
0
-12
-7
-12
-29
-25
-29
-42
EBITDA
0
0
0
-12
-7
-12
-30
-27
-29
-42
Interest Expense
-
-
-
-
-
-
1
1
-
-
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
0
0
0
-12
-7
-12
-30
-27
-30
-42
Income Tax Expense
-
0
-1
0
1
0
1
1
-29
-
Net Income
0
0
0
-12
-7
-12
-30
-28
-30
-42
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
-9.88%
-110838.76%
-16762.43%
-7659.63%
-19360.00%
-300585.71%

Inmune Bio Inc Quarterly Cash Flow

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Net Income
-8
-8
-11
-9
-12
-9
-9
-24
-6
Operating Cash Flow
-4
-3
-7
-7
-6
-11
-6
-7
-5
Investing Cash Flow
-2
2
-
-
-
-
-
0
0
Financing Cash Flow
-1
-2
-2
12
9
-2
5
22
-
Change in Cash
-6
-5
-9
5
2
-12
-1
14
-5

Inmune Bio Inc Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
0
0
-12
-7
-12
-30
-27
-30
-42
Operating Cash Flow
0
0
-2
-5
-8
-28
-22
-11
-33
Investing Cash Flow
0
0
-15
-15
-15
-15
-
-
-
Financing Cash Flow
0
2
0
12
23
96
0
-4
18
Change in Cash
0
1
-1
6
14
52
-22
-16
-14

Global Institutional Holdings in Inmune Bio Inc

Funds
Holdings
BlackRock Inc
4.46%
Mccormack Advisors International
0.18%
Geode Capital Management, LLC
1.66%
Dauntless Investment Group, LLC
1.15%
Jane Street Group LLC
0.19%
See all

Insights on Inmune Bio Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -24.45M → -6.47M (in $), with an average increase of 277.9% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 14.0K → 50.0K (in $), with an average increase of 72.0% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 18.2% return, outperforming this stock by 103.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 62.6% return, outperforming this stock by 144.0%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 year, INMB stock has moved down by -85.1%

About Inmune Bio Inc

inmune bio inc. is a clinical stage immuno-oncology company focused on harnessing the patient’s immune system to treat cancer. inkmune, the company’s lead product, primes patient’s nk cells (natural killer cells) to kill cancer. inmune is targeting residual disease, the cancer cells that survive initial treatments that return to cause the cancer relapse. by controlling residual disease, patients may live longer. using a novel mechanism of action and a precision medicine approach, inkmune therapy should enhance nk cells’ ability to eliminate residual disease.
OrganisationInmune Bio Inc
Headquarters225 NE Mizner Blvd., Boca Raton, FL, United States, 33432
IndustryMedical Specialties
CEOMr. David J. Moss M.B.A.
E-voting on sharesClick here to vote

Key Management of Inmune Bio Inc

Name

Title

Mr. Joshua S. Schoonover Esq.

General Counsel

Mr. David J. Moss M.B.A.

President, CEO, Treasurer, Secretary & Director

Dr. Mark William Lowdell Ph.D.

Chief Scientific Officer & Chief Manufacturing Officer

Mr. Cory Randall Ellspermann

Interim Chief Financial Officer

Mr. Daniel Frederick Carlson

Head of Investor Relations

FAQs

What is Inmune Bio Inc share price today?

Inmune Bio Inc share price today is $1.14 as on at the close of the market. Inmune Bio Inc share today touched a day high of $1.2 and a low of $1.13.

What is the 52 week high and 52 week low for Inmune Bio Inc share?

Inmune Bio Inc share touched a 52 week high of $11.64 on and a 52 week low of $1.12 on . Inmune Bio Inc stock price today i.e. is closed at $1.14,which is 90.21% down from its 52 week high and 1.79% up from its 52 week low.

What is Inmune Bio Inc's market capitalisation today?

Inmune Bio Inc market capitalisation is $0.00T as on .

How to invest in Inmune Bio Inc Stock (INMB) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Inmune Bio Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Inmune Bio Inc Shares that will get you 1.3158 shares as per Inmune Bio Inc share price of $1.14 per share as on March 28, 2026 at 1:29 am IST.

What is the minimum amount required to buy Inmune Bio Inc Stock (INMB) from India?

Indian investors can start investing in Inmune Bio Inc (INMB) shares with as little as ₹94.63 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹946.30 in Inmune Bio Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Inmune Bio Inc share’s latest price of $1.14 as on March 28, 2026 at 1:29 am IST, you will get 8.7719 shares of Inmune Bio Inc. Learn more about fractional shares .